Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687167 · ClinicalTrials.gov registry record · Phase 1
Fed Bioavailability Study of Zonisamide Capsules
A Phase 1 study, sponsored by Mutual Pharmaceutical Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT00687167 is a Phase 1 study that has completed, run by Mutual Pharmaceutical Company. The registered enrollment target is 34 participants.
The verdict
NCT00687167, a Phase 1 study, has completed, sponsored by Mutual Pharmaceutical Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the relative bioavailability (rate and extent of absorption) of a test formulation of zonisamide capsules compared to the reference formulation, Zonegran® (zonisamide)capsules, after a single oral dose administered under non-fasting conditions.
Interventions
- DRUG Zonisamide 100 mg Capsule
- DRUG Zonisamide (Zonegran®) 100 mg Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2005-01 |
| Est. Completion | 2005-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687167
The ClinicalTrials.gov registry entry for NCT00687167 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mutual Pharmaceutical Company, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zonisamide 100 mg Capsule is the first listed.
NCT00687167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687167 about?
NCT00687167 is a clinical study titled "Fed Bioavailability Study of Zonisamide Capsules". The purpose of this study is to evaluate the relative bioavailability (rate and extent of absorption) of a test formulation of zonisamide capsules compared to the reference formulation, Zonegran® (zonisamide)capsules, after a single oral dose administered under non-fasting conditions.
What is the current status of trial NCT00687167?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2005-01. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00687167?
The interventions under investigation include: Zonisamide 100 mg Capsule (DRUG), Zonisamide (Zonegran®) 100 mg Capsule (DRUG).
Who is sponsoring clinical trial NCT00687167?
This trial is sponsored by Mutual Pharmaceutical Company, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.